A 12-Week, Randomized, Open-Label, 3 Arm Parallel Group, Multicenter, Phase IIIb Study Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin Achieving NCEP ATP [National Cholesterol Education Program Adult Treatment Panel] III LDL-C [low-density lipoprotein cholesterol] Goals in High Risk Subjects With Hypercholesterolaemia in the Managed Care Setting

Trial Profile

A 12-Week, Randomized, Open-Label, 3 Arm Parallel Group, Multicenter, Phase IIIb Study Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin Achieving NCEP ATP [National Cholesterol Education Program Adult Treatment Panel] III LDL-C [low-density lipoprotein cholesterol] Goals in High Risk Subjects With Hypercholesterolaemia in the Managed Care Setting

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Apr 2008

At a glance

  • Drugs Atorvastatin; Rosuvastatin; Simvastatin
  • Indications Hypercholesterolaemia; Hyperlipidaemia
  • Focus Therapeutic Use
  • Acronyms SOLAR
  • Sponsors AstraZeneca
  • Most Recent Events

    • 17 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top